openPR Logo
Press release

Parkinson’s Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments

02-23-2017 06:39 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: PR Market Report

Parkinson’s Disease Therapeutics in Major Developed Markets

Parkinson’s Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments Summary Parkinsons Disease (PD) is a progressive, chronic neurodegenerative condition, which is currently incurable. It is associated with old age, and characterized by the loss of neurons in the substantia nigra region of the brain. The global Parkinsons Disease (PD) prevalence was estimated at 16.1 million in 2011, and after Alzheimers disease it is the second most common neurodegenerative disease worldwide.

Parkinsons Disease (PD) is a progressive disease and, although not fatal, it can develop severe symptoms and complications that significantly impact upon the patients quality of life. Symptoms for each stage can be categorized into early, moderate and advanced stages. Major motor symptoms of Parkinsons Disease (PD) include tremors and difficulty walking. Parkinsons Disease (PD) also gives rise to non-motor symptoms, such as dementia, depression, hallucinations and loss of taste and smell. There are several different drug classes available to relieve Parkinsons Disease (PD) symptoms. The aim is for treatments to increase dopamine levels, which is substantially diminished in brains affected by Parkinsons Disease (PD). The most common therapies include levodopa, dopamine agonists and Monoamine Oxidase-B (MAO-B) inhibitors, with the choice of therapies dependent on patient symptoms and lifestyle. As the disease develops, the medication will need to be taken more strictly, due to the effect of drugs wearing off (known as off- time), which causes symptoms to return before the next dose.

With the current marketed drugs focusing primarily on symptomatic relief, Parkinsons Disease (PD) remains incurable, with a huge unmet need for disease-modifying therapies. However, due to the lack of clearly established clinical trial methodologies, replication of the benefits demonstrated by neuroprotective agents in the laboratory to human trials has proved challenging. More importantly, due to an incomplete understanding of the underlying mechanisms that cause the disease, a viable therapeutic target to halt or slow disease progression is currently not in scope, which limits the effectiveness of current product development programs.

Read More @ https://goo.gl/yzHhfb

Scope -

A brief introduction to Parkinson’s Disease (PD), including pathogenesis, disease staging, diagnosis and treatment algorithms - Comprehensive analysis of the drugs available for the treatment of PD, covering their safety, efficacy, treatment patterns, and strengths/weaknesses, as well as a heat map comparing drugs in terms of safety and efficacy - Comprehensive analysis of the pipeline for Parkinson’s Disease (PD) therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market in the forecast period, on the basis of Phase distribution, molecule type and molecular target - Additional thorough analysis of pipeline drug clinical trials by Phase, molecule type, trial size, trial duration, and program failure rate for each molecule type and mechanism of action - Multi-scenario market forecast data to 2021, taking into account how it will be affected by the introduction of new drugs, the expiry of key patents on current drugs, and changes in disease epidemiology across the key developed markets of the US, Canada, Japan, Germany, the UK, France, Italy and Spain - Discussion of the drivers of and barriers to market growth -

Discussion of the licensing and co-development deals landscape in Parkinson’s Disease (PD), by stage of development, molecule type and mechanism of action, as well as analysis of both licensing and co-development deals by year, and network maps of licensing and co-development deals Reasons to buy - Understand the different levels of Parkinson’s Disease (PD) therapy from early-stage to advanced - Understand the vast scope of the pipeline, including which molecule types and mechanisms of action are prominent - Observe the trends in clinical trial duration and size among clinical Phases and molecule types, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or forthcoming developmental programs for Parkinson’s Disease (PD) therapeutics -

Observe the trends in clinical trial duration and size among clinical Phases, between molecule types and mechanisms of action, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for Parkinson’s Disease (PD) therapeutics - Assess the potential clinical and commercial impact of current late-stage pipeline molecules on the Parkinson’s Disease (PD) therapeutics market

Visit Our Site @ http://www.provueresearch.com

About Us
Provue Market Research is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles.

Contact Us
Provue Research
14715 Prairie Ave,
Lawndale, CA, 90260,
California USA
Tel:- +18889204862
Email: info@provueresearch.com
Web: http://provueresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parkinson’s Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments here

News-ID: 447806 • Views:

More Releases from PR Market Report

Global Sodium Persulfate Market Research Report 2017
Global Sodium Persulfate Market Research Report 2017
Sodium Persulfate Market Provue Market Research has recently declared the expansion of “Worldwide Sodium Persulfate Market Detailed Analysis Report 2017-2022" that gives the market study of “Sodium Persulfate Market “ across the global, regional and country level. Sodium Persulfate Market : Global Industry Analysis, Capacity, Production, Price, Revenue, Size, Share, Growth, Trends, and Forecasts 2017-2022 Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share
Global Butanediol (BDO) Market Research Report 2017
Global Butanediol (BDO) Market Research Report 2017
Butanediol (BDO) Market Provue Market Research has recently declared the expansion of “Worldwide Butanediol (BDO) Market Detailed Analysis Report 2017-2022" that gives the market study of “Butanediol (BDO) Market “ across the global, regional and country level. Butanediol (BDO) Market : Global Industry Analysis, Capacity, Production, Price, Revenue, Size, Share, Growth, Trends, and Forecasts 2017-2022 Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share
World XRF Analysers Market by Product Type, Market, Players and Regions-Forecast to 2022
World XRF Analysers Market by Product Type, Market, Players and Regions-Forecast …
XRF Analysers Market Provue Market Research has recently declared the expansion of “Worldwide XRF Analysers Market Detailed Analysis Report 2017-2022" that gives the market study of “ XRF Analysers Market“ across the global, regional and country level. XRF Analysers Market: Global Industry Analysis, Capacity, Production, Price, Revenue, Size, Share, Growth, Trends, and Forecasts 2017-2022 According to our research, the global XRF Analyzers markets has a total value of 1046.71 M USD back in
Global Intelligent Transportation System Market – Trends Forecast 2016-2022
Global Intelligent Transportation System Market – Trends Forecast 2016-2022
Intelligent Transportation System Market Provue Market Research has recently declared the expansion of “Worldwide Intelligent Transportation System Market Detailed Analysis Report 2017-2022" that gives the market study of “ Intelligent Transportation System Market“ across the global, regional and country level. Intelligent Transportation System Market: Global Industry Analysis, Capacity, Production, Price, Revenue, Size, Share, Growth, Trends, and Forecasts 2017-2022 Intelligent Transport System (ITS) is a computerized system with diverse applications connected with vehicle transportation,

All 5 Releases


More Releases for Disease

Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and